A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

The Nectar Ultra Hybrid is a luxury hybrid mattress that combines layers of dense memory foam with responsive zoned foam and ...

Each is designed to regulate your temperature through the night, but beyond that these technologies work in different ways ...

eIsraeli National Hemophilia Center and Thrombosis Unit and The Amalia Biron Thrombosis Research Institute, Sheba Medical Center, Tel Hashomer, Israel fChildren's Hospital Los Angeles, University of ...

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...

Braintree ® intends to submit results from the TRIUMpH Phase 3 studies to a high impact, peer reviewed journal along with presentation of this data at a leading gastroenterology conference in the ...

Mark Huffman has been a consumer news reporter for ConsumerAffairs since 2004. He covers real estate, gas prices and the economy and has reported extensively on negative-option sales. He was ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. The phase 3 study linked the oral GLP-1 drug orforglipron to similar reductions in blood glucose and body ...

PRINCETON, NJ, USA I April 14, 2025 I Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with ...

Ironwood Pharmaceuticals is mulling its options after the FDA demanded another phase 3 trial before it will make an approval decision on the biopharma’s long-acting GLP-2 analog. The drug ...